1. Home
  2. NEPH vs TOI Comparison

NEPH vs TOI Comparison

Compare NEPH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • TOI
  • Stock Information
  • Founded
  • NEPH 1997
  • TOI 2007
  • Country
  • NEPH United States
  • TOI United States
  • Employees
  • NEPH N/A
  • TOI N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • TOI Medical/Nursing Services
  • Sector
  • NEPH Health Care
  • TOI Health Care
  • Exchange
  • NEPH Nasdaq
  • TOI Nasdaq
  • Market Cap
  • NEPH 36.1M
  • TOI 266.8M
  • IPO Year
  • NEPH 2004
  • TOI N/A
  • Fundamental
  • Price
  • NEPH $4.03
  • TOI $2.52
  • Analyst Decision
  • NEPH Buy
  • TOI
  • Analyst Count
  • NEPH 1
  • TOI 0
  • Target Price
  • NEPH $5.00
  • TOI N/A
  • AVG Volume (30 Days)
  • NEPH 67.9K
  • TOI 2.0M
  • Earning Date
  • NEPH 08-07-2025
  • TOI 08-12-2025
  • Dividend Yield
  • NEPH N/A
  • TOI N/A
  • EPS Growth
  • NEPH N/A
  • TOI N/A
  • EPS
  • NEPH 0.08
  • TOI N/A
  • Revenue
  • NEPH $15,517,000.00
  • TOI $403,152,000.00
  • Revenue This Year
  • NEPH $17.06
  • TOI $23.95
  • Revenue Next Year
  • NEPH $12.20
  • TOI N/A
  • P/E Ratio
  • NEPH $53.08
  • TOI N/A
  • Revenue Growth
  • NEPH 10.34
  • TOI 17.64
  • 52 Week Low
  • NEPH $1.36
  • TOI $0.13
  • 52 Week High
  • NEPH $5.00
  • TOI $3.50
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 56.63
  • TOI 51.23
  • Support Level
  • NEPH $3.83
  • TOI $2.02
  • Resistance Level
  • NEPH $4.39
  • TOI $2.57
  • Average True Range (ATR)
  • NEPH 0.47
  • TOI 0.20
  • MACD
  • NEPH -0.07
  • TOI 0.00
  • Stochastic Oscillator
  • NEPH 43.27
  • TOI 82.79

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: